Infosys surprised the market in its third‑quarter report, delivering a modest yet meaningful 0.6% quarter‑on‑quarter revenue increase that beat the consensus estimate of a 0.5% decline. The lift came from a blend of strategic wins, a surge in discretionary spending, and growing client enthusiasm for AI‑driven solutions.
Revenue Performance Defies Seasonal Pressure
Despite the usual seasonal slowdown and the absence of price pass‑throughs, Infosys managed to grow top‑line revenue. The company attributes this resilience to two primary drivers:
- Ramp‑up of a large NHS contract that added significant billings.
- Higher discretionary spend from existing clients seeking digital transformation.
These factors helped the firm post a 0.6% constant‑currency (CC) growth, contrasting sharply with the market’s expectation of a 0.5% contraction.
Deal Momentum Accelerates – $4.8 bn TCV in Q3
The quarter’s headline was a massive $4.8 billion total contract value (TCV) win, representing a 60% jump from the previous quarter. Even after stripping out the NHS deal (≈$1.6 bn), the remaining pipeline still eclipsed Q2’s wins, underscoring a robust order book.
- 9‑month FY26 TCV grew 30% year‑on‑year.
- Large‑deal pipeline signals a durable revenue base for FY27 and beyond.
AI Adoption Becomes a Revenue Engine
Clients are increasingly embedding generative AI into core business functions, a trend that Infosys is capitalising on through its AI‑first consulting and implementation services. This shift is not just a headline—it is directly supporting topline growth as enterprises look to modernise processes, reduce costs, and unlock new revenue streams.
Margin Outlook Remains Tight but Positive
Management expects margins to stay within a controlled band. While higher spending on sales & marketing, AI talent acquisition, and compliance with the new Labour Code will pressure margins, these costs are partially offset by the high‑margin Project Maximus initiative.
- FY26E margin: flat YoY.
- FY27E margin: +30 basis points YoY.
- FY28E margin: +40 basis points YoY.
Guidance and Valuation Implications
Looking ahead, Infosys projects revenue growth of 3.2% in FY26, accelerating to 6.0% in FY27 and 6.8% in FY28, all on a constant‑currency basis. Applying a 22‑times FY28 earnings multiple yields a target price of roughly ₹1,900 per share, reinforcing a BUY recommendation.
What Retail Investors Should Watch
Key watch‑points for investors include:
- Execution of the AI‑centric roadmap and its impact on deal velocity.
- Progress on large‑deal conversions, especially outside the NHS segment.
- Margin trends as the company balances reinvestment with profitability.
In short, Infosys appears to be laying a solid foundation for a higher growth trajectory, with AI and large contracts serving as twin engines for FY27 and FY28.
Remember, this analysis reflects current information and should not be taken as a definitive prediction. Conduct your own due diligence before making any investment decisions.